Trends in stage-specific breast cancer incidence and overdiagnosis in NSW
|
|
- Nancy Marshall
- 5 years ago
- Views:
Transcription
1 Trends in stage-specific breast cancer incidence and overdiagnosis in NSW Presented by Dr Gemma Jacklyn Sydney School of Public Authors Gemma Jacklyn, Kevin McGeechan, Les Irwig, Nehmat Houssami, Stephen Morrell, Katy Bell, Alexandra Barratt
2 Background Two prerequisites for screening to lower cancer mortality 1. Screening must bring forward in time the diagnosis of cancers destined to cause death Find more early-stage cancer BUT Must be followed by a decline in late-stage cancer 2. Early treatment of cancers destined to cause death must provide some benefit over late treatment after clinical presentation Stage-specific incidence of breast cancer in NSW
3 Effective screening Fig 1. Optimal screening program Incidence Early-stage cancer Overall cancer rate Late-stage cancer Introduction of screening Time Stage-specific incidence of breast cancer in NSW
4 Aims Examine temporal trends in the incidence of early- and late-stage incidence of breast cancer in NSW women Estimate the percentage risk of overdiagnosis attributable to screening mammography in NSW Stage-specific incidence of breast cancer in NSW
5 Methods Setting: NSW, Australia from Participants: Stage: Women of all ages with a histologically verified breast cancer diagnosis recorded in the NSW Cancer registry Overdiagnosis: Women aged 50 years and older Intervention: BreastScreen NSW ( ) Measurement: Early-stage cancer (carcinoma in situ & localised) Late-stage cancer (regional & distant metastases) Stage-specific incidence of breast cancer in NSW
6 Methods: stage Analysed trends over 25 years to allow surplus of early-stage cancer to translate into decrease in late-stage cancer Rates were standardised by 5-year age intervals within broad age groups, using the Australian 2001 population. Stage-specific incidence of breast cancer in NSW
7 Heading Results: stage Pre-screening Medicare BreastScreen mammography roll-out Pilot screening Established screening Digital Early-stage Breast cancer incidence (cases/100,000 women) Late-stage Women aged 50 years and older Early-stage Late-stage Women younger than 50 years Figure 2. Incidence of Stage-Specific Breast Cancer in NSW women, Note: Rates were standardised by 5-year age intervals within broad age groups, using the Australian 2001 population.
8 Heading Results: stage Figure 3. Incidence of Stage-Specific Breast Cancer in NSW women aged years, Note: Rates were standardised by 5-year age intervals within broad age groups, using the Australian 2001 population.
9 Results: stage Incidence for all stages higher than prescreening levels The number of women diagnosed with early-stage breast cancer at diagnosis has tripled No decrease in incidence of late-stage breast cancer at diagnosis In women too young to screen the incidence of late-stage breast cancer also increased, whereas localised disease was stable Stage-specific incidence of breast cancer in NSW
10 Methods: overdiagnosis Estimate of expected incidence in unscreened women 1. Poisson regression modelling to estimate annual counts of early- and late-stage breast cancer in NSW women from ; 2. Incidence trends in contemporary cohort of NSW women who did not attend screening regularly (age years). Adjustment for changes in risk factors Capped the observed estimates of breast cancer for hormone-replacement therapy (HRT) use from Overdiagnosis of breast cancer in NSW
11 Methods: overdiagnosis Calculation: Calculated difference in observed counts relative to the expected in each subsequent calendar year Excess cancers / cancers diagnosed in women invited to screening Lead time adjustment: 1. Included cancer cases in women who were older than the upper age limit of the screening program. 2. Analysed trends over 25 years to allow for equilibrium between initial incidence peak and compensatory drop Overdiagnosis of breast cancer in NSW, Australia
12 Heading Results Table 1 Overdiagnosis in NSW women aged 50 years and older invited to screening, Method DCIS Invasive Distant Total Prescreening trend (women aged 50+) Contemporary trend (women aged 40-44) 13.4% 23.0% -7.1% 29.3% 13.6% 25.5% -15.9% 23.1% Overdiagnosis of breast cancer in NSW, Australia
13 Results Overdiagnosis does not simply involve DCIS more than half are invasive breast cancer Around one quarter of all newly diagnosed DCIS and invasive breast cancer cases in women aged 50+ are overdiagnosed Approximately 5 additional cases of breast cancer are detected for every metastatic breast cancer prevented Overdiagnosis of breast cancer in NSW, Australia
14 Strengths & limitations 40 years of data on histologically verified stage-specific breast cancer at diagnosis Observational study design Don t know what the trends would have been in the absence of screening Stage-specific incidence of breast cancer in NSW
15 Conclusion Screening mammography was not associated with a reduction in the incidence of late-stage breast cancer in NSW We estimate that around one quarter of all breast cancer cases are overdiagnosed Some of the expected benefits of screening mammography in NSW may not have been realised Overdiagnosis of breast cancer in NSW, Australia
16 Publication details Jacklyn G, McGeechan K, Irwig L, Houssami N, Morrell S, Bell K, Barratt A. Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography. Breast Cancer Research and Treatment 2017;66(3): doi: /s x
17 Acknowledgements Stage-specific incidence of breast cancer in NSW
OVERDETECTION INFORMATION IN A BREAST CANCER SCREENING DECISION AID
OVERDETECTION INFORMATION IN A BREAST CANCER SCREENING DECISION AID RANDOMISED CONTROLLED TRIAL Jolyn Hersch SYDNEY MEDICAL SCHOOL Screening and Test Evaluation Program (STEP) Sydney School of Public Health
More informationExamination of the impact of shifting practice from plain film mammography to digital mammography
Examination of the impact of shifting practice from plain film mammography to digital mammography Presented by Rachel Farber Sydney Medical School, School of Public Health The University of Sydney Page
More informationCite this article as: BMJ, doi: /bmj f (published 8 March 2005)
Cite this article as: BMJ, doi:10.1136/bmj.38398.469479.8f (published 8 March 2005) Model of outcomes of screening mammography: information to support informed choices Alexandra Barratt, Kirsten Howard,
More informationBreast Screening: risks if you do and risks if you don t. Stephen W. Duffy Wolfson Institute of Preventive Medicine
Breast Screening: risks if you do and risks if you don t Stephen W. Duffy Wolfson Institute of Preventive Medicine General principle There is often discussion of benefits and harms of breast screening
More informationQuantifying Breast Cancer Over-diagnosis in an Organised Mammography Screening Program
Quantifying Breast Cancer Over-diagnosis in an Organised Mammography Screening Program KERRI BECKMANN BSc (Hons) MPH September 2014 Discipline of Public Health School of Population Health Faculty of Health
More informationInterval Cancers in BreastScreen Aotearoa
Interval Cancers in BreastScreen Aotearoa 2008 2009 Released 2018 nsu.govt.nz Citation: National Screening Unit. 2018. Interval Cancers in BreastScreen Aotearoa 2008 2009. Wellington: Ministry of Health.
More informationSummary of the BreastScreen Aotearoa Mortality Evaluation
Summary of the BreastScreen Aotearoa Mortality Evaluation 1999 2011 Released 2015 nsu.govt.nz Citation: Ministry of Health. 2015. Summary of the BreastScreen Aotearoa Mortality Evaluation 1999 2011. Wellington:
More informationCancer screening: Breast
Cancer control in NSW: 2016 Cancer screening: Breast Introduction In NSW, breast cancer accounted for 27.4 per cent of all new cancer cases in women, and 14.6 per cent of all cancer mortality in women
More informationBreastScreen Victoria Annual Statistical Report
BreastScreen Victoria Annual Statistical Report 2010 BREASTSCREEN VICTORIA: ANNUAL STATISTICAL REPORT, 2010 Produced by: BreastScreen Victoria Coordination Unit Level 1, 31 Pelham Street, Carlton South
More informationQuantifying Breast Cancer Over-diagnosis in an Organised Mammography Screening Program
Quantifying Breast Cancer Over-diagnosis in an Organised Mammography Screening Program KERRI BECKMANN BSc (Hons) MPH September 2014 Discipline of Public Health School of Population Health Faculty of Health
More informationBreastScreen Victoria Annual Statistical Report
BreastScreen Victoria Annual Statistical Report 005 Produced by: BreastScreen Victoria Coordination Unit Level, Pelham Street, Carlton South Victoria 05 PH 0 9660 6888 FX 0 966 88 EM info@breastscreen.org.au
More informationGlass Half Full, Glass Half Empty: Evidence and Perspectives on Overdiagnosis and Cancer Screening:
Glass Half Full, Glass Half Empty: Evidence and Perspectives on Overdiagnosis and Cancer Screening: Breast cancer screening in the context of overdiagnosis Tracy Onega, MS, PhD Associate Professor of Community
More informationTrends in Cancer Survival in NSW 1980 to 1996
Trends in Cancer Survival in NSW 19 to 1996 Xue Q Yu Dianne O Connell Bruce Armstrong Robert Gibberd Cancer Epidemiology Research Unit Cancer Research and Registers Division The Cancer Council NSW August
More informationBreastScreen Victoria Annual Statistical Report
BreastScreen Victoria Annual Statistical Report CONTENTS FIGURES AND TABLES... Figures... Tables... 3 INTRODUCTION... 5 SECTION MAXIMISING PARTICIPATION... 6 Program acceptance... 6 Eligibility... 6 Inviting
More informationBreastScreen Victoria Annual Statistical Report
BreastScreen Victoria Annual Statistical Report 29 BREASTSCREEN VICTORIA: ANNUAL STATISTICAL REPORT, 29 Produced by: BreastScreen Victoria Coordination Unit Level, 3 Pelham Street, Carlton South Victoria
More informationGENERAL COMMENTS. The Task Force Process Should be Fully Open, Balanced and Transparent
December 9, 2013 Submitted Electronically United States Preventive Services Task Force c/o Dr. Robert Cosby Agency for Healthcare Research and Quality 540 Gaither Road Rockville, MD 20850 RE: USPSTF Draft
More informationCancer screening Pros, cons, choice, and the patient
THEME CANCER SCREENING Lyndal Trevena MBBS(Hons), MPhilPH, PhD, is Senior Lecturer and Sub-Dean, Centre for Medical Psychology and Evidence-Based Decision- Making (CeMPED), School of Public Health, University
More informationBreast imaging in general practice
Breast series CLINICAL PRACTICE Breast imaging in general practice Nehmat Houssami, MBBS, FAFPHM, FASBP, PhD, is Associate Clinical Director, NSW Breast Cancer Institute, Westmead Hospital, Honorary Senior
More informationBREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School
BREAST MRI Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Any assessment of the breast parenchyma requires the administration
More informationOverdiagnosis of breast cancer in population screening: does it make breast screening worthless?
Cancer Biol Med 2017. doi: 10.20892/j.issn.2095-3941.2016.0050 REVIEW Overdiagnosis of breast cancer in population screening: does it make breast screening worthless? Nehmat Houssami Sydney School of Public
More informationNational Cervical Screening Programme. Annual Report 2014
National Cervical Screening Programme Annual Report 2014 Report prepared February 2017 Revised May 2017 Finalised June 2017 Report prepared by Megan Smith, Leanne Rumlee and Karen Canfell. Cancer Research
More informationBMC Women's Health. Open Access. Abstract
BMC Women's Health BioMed Central Research article Overdiagnosis in organised mammography screening in Denmark. A comparative study Karsten J Jørgensen* 1, Per-Henrik Zahl 2 and Peter C Gøtzsche 1 Open
More informationCancer in Australia: Actual incidence data from 1991 to 2009 and mortality data from 1991 to 2010 with projections to 2012
bs_bs_banner Asia-Pacific Journal of Clinical Oncology 2013; 9: 199 213 doi: 10.1111/ajco.12127 ORIGINAL ARTICLE Cancer in Australia: Actual incidence data from 1991 to 2009 and mortality data from 1991
More informationCancer Screening: Evidence, Opinion and Fact Dialogue on Cancer April Ruth Etzioni Fred Hutchinson Cancer Research Center
Cancer Screening: Evidence, Opinion and Fact Dialogue on Cancer April 2018? Ruth Etzioni Fred Hutchinson Cancer Research Center Three thoughts to begin 1. Cancer screening is a good idea in principle Detect
More informationCohort and Case Control Analyses of Breast Cancer Mortality: BreastScreen Aotearoa
Cohort and Case Control Analyses of Breast Cancer Mortality: BreastScreen Aotearoa 1999-2011 by Stephen Morrell, 1 Richard Taylor, 1 David Roder, 2 Bridget Robson 3 1. School of Public Health and Community
More informationInterval cancers in BreastScreen Aotearoa
in BreastScreen Aotearoa 1999 2007 Richard Taylor Madeleine Wall Stephen Morrell Independent Monitoring Group School of Public Health and Community Medicine University of New South Wales for BreastScreen
More informationTemporal trends in the incidence of molecular subtypes of breast cancer. Jonine D. Figueroa, Ph.D., M.P.H.
Temporal trends in the incidence of molecular subtypes of breast cancer Jonine D. Figueroa, Ph.D., M.P.H. Epidemiology: Health data science Study of the distribution and determinants of health and disease
More informationShould I Get a Mammogram?
Should I Get a Mammogram? Ages 75+ BREAST CANCER SCREENING This photo is for illustrative purposes only, and the person depicted in the photograph is a model. An affiliation between Central Washington
More informationMammographic screening for breast cancer: A review
REVIEW ARTICLE Mammographic screening for breast cancer: A review Warwick Lee 1,2 & Gudrun Peters 3,4 1 BreastScreen NSW, Cancer Institute NSW, Alexandria, New South Wales 1435, Australia 2 Discipline
More informationCONTENTS NOTE TO THE READER...1 LIST OF PARTICIPANTS...3
CONTENTS NOTE TO THE READER....1 LIST OF PARTICIPANTS....3 WORKING PROCEDURES...7 A. GENERAL PRINCIPLES AND PROCEDURES...7 1. Background....7 2. Scope....7 3. Objectives....8 4. Meeting participants...8
More informationCancer survival and prevalence in Tasmania
Cancer survival and prevalence in Tasmania 1978-2008 Cancer survival and prevalence in Tasmania 1978-2008 Tasmanian Cancer Registry University of Tasmania Menzies Research Institute Tasmania 17 Liverpool
More informationParallel Sessions: 2:00 3:00 p.m.
Parallel Session A Room 403 Parallel Sessions: 2:00 3:00 p.m. Parallel Session B Room 404 Parallel Session C Room 405 Parallel Session D Room 406 2:00 Informing women about overdetection in breast cancer
More informationBreastScreen-based mammography screening in women with a personal history of breast cancer, Western Australian study
Research Nehmat Houssami MB BS, FAFPHM, PhD, Principal Research Fellow and Associate Professor (Research) 1 Janette J Tresham BSc(Agric), Data Manager 2 Lin Fritschi MB BS, FAFPHM, PhD, Professor 3 Liz
More informationProgramme Report
Programme Report 2015-2016 Contents Introduction from the Head of Screening, National Screening Service 2 Highlights of 2015-2016 4 Programme report 5 References 19 Introduction from the Head of Screening,
More informationAssociation of symptoms and interval breast cancers in the mammography-screening programme: population-based matched cohort study
www.nature.com/bjc ARTICLE Epidemiology Association of symptoms and interval breast cancers in the mammography-screening programme: population-based matched cohort study Deependra Singh 1,, Joonas Miettinen
More informationMammography and Other Screening Tests. for Breast Problems
301.681.3400 OBGYNCWC.COM Mammography and Other Screening Tests What is a screening test? for Breast Problems A screening test is used to find diseases, such as cancer, in people who do not have signs
More information- The University of. - Student. Western Australia, Crawley, Western Australia
Title: Is Step Down Assessment of Screen Detected Lesions as Safe as Workup at a Metropolitan Assessment Centre? Authors Author name Degrees/ Fellowships Position Institution Phone Email Jade P Hughes
More informationOverdetection in breast cancer screening: development and preliminary evaluation of a decision aid
To cite: Hersch J, Jansen J, Barratt A, et al. Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid. BMJ Open 2014;4:e006016. doi:10.1136/bmjopen-2014-006016
More informationHow often should I get a mammogram?
How often should I get a mammogram? Ages 50-74 BREAST CANCER SCREENING This photo is for illustrative purposes only, and the person depicted in the photograph is a model. An affiliation between Central
More informationAscertaining and reporting interval cancers in BreastScreen Aotearoa: A protocol NATIONAL SCREENING UNIT (NSU) MINISTRY OF HEALTH
Ascertaining and reporting interval cancers in BreastScreen Aotearoa: A protocol NATIONAL SCREENING UNIT (NSU) MINISTRY OF HEALTH Dr. Simon Baker National Screening Unit Ministry of Health October 2005
More informationPublic Health Agency NORTHERN IRELAND BREAST SCREENING PROGRAMME ANNUAL REPORT & STATISTICAL BULLETIN QUALITY ASSURANCE REFERENCE CENTRE
Public Health Agency Improving Your Health and Wellbeing NORTHERN IRELAND BREAST SCREENING PROGRAMME ANNUAL REPORT & STATISTICAL BULLETIN 2010-2011 QUALITY ASSURANCE REFERENCE CENTRE August 2012 1 2 Contents
More informationAtypical proliferative lesions diagnosed on core biopsy - 6 year review
Atypical proliferative lesions diagnosed on core biopsy - 6 year review Dr Angela Harris, Dr Julie Weigner & Dr Ricardo Vilain NSW Health Pathology Pathology North, Hunter Anatomical Pathology & Cytology
More informationLinking Oncotype Dx results to SEER data and patient report to assess challenges in individualizing breast cancer care
Linking Oncotype Dx results to SEER data and patient report to assess challenges in individualizing breast cancer care June 16, 2015 NAACCR, Charlotte, NC Ann Hamilton, Ph.D. Keck School of Medicine, University
More informationBreastScreen Victoria tomosynthesis screening trial, Maroondah pilot: Preliminary Outcomes
BreastScreen Victoria tomosynthesis screening trial, Maroondah pilot: Preliminary Outcomes Dr Darren Lockie, Director and Chief Radiologist, Maroondah BreastScreen, Eastern Health Ms Michelle Clemson,
More informationAudit. Public Health Monitoring Report on 2006 Data. National Breast & Ovarian Cancer Centre and Royal Australasian College of Surgeons.
National Breast & Ovarian Cancer Centre and Royal Australasian College of Surgeons Audit Public Health Monitoring Report on 2006 Data November 2009 Prepared by: Australian Safety & Efficacy Register of
More informationScreening Overdiagnosis. Archie Bleyer, MD Department of Radiation Medicine Knight Cancer Institute at the Oregon Health & Science University
Screening Overdiagnosis Archie Bleyer, MD Department of Radiation Medicine Knight Cancer Institute at the Oregon Health & Science University NNS Bottom Line I To prevent 1 death from breast cancer, 2,250
More informationBreast Cancer Risk and Disease Outcomes for Australian Aboriginal Women
Breast Cancer Risk and Disease Outcomes for Australian Aboriginal Women On the Agenda How frequent is breast cancer in the Indigenous population relative to non- Indigenous people. How do breast cancer
More informationBREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School
BREAST MRI Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Any assessment of the breast parenchyma requires the administration
More informationBreast health and screening
Breast health and screening Dr Kathy Wong MBBS (HK), FRCR (UK), FHKCR FHKAM (Radiology) Clinical Radiologist Department of Diagnostic and Interventional Radiology Kwong Wah Hospital Questions regarding
More informationBreast Cancer Risk Factors 8/3/2014
Breast Cancer Screening: Changing Philosophies in Educating Women and Teens Courtney Benedict CNM MSN Session Objectives Explain the rationale for initiation and frequency of clinical breast exams to clients
More informationNORTHERN IRELAND BREAST SCREENING PROGRAMME ANNUAL REPORT & STATISTICAL BULLETIN
NORTHERN IRELAND BREAST SCREENING PROGRAMME ANNUAL REPORT & STATISTICAL BULLETIN 212-213 August 214 QUALITY ASSURANCE REFERENCE CENTRE 1 2 Contents Page 1 Summary 4 2 Introduction 8 3 Key developments
More informationLearning and Earning with Gateway Professional Education CME/CEU Webinar Series. Breast Cancer Screening September 21, :00pm 1:00pm
Learning and Earning with Gateway Professional Education CME/CEU Webinar Series Breast Cancer Screening September 21, 2017 12:00pm 1:00pm Robert A. Smith, PhD Vice President, Cancer Screening American
More informationTHE ISSUE OF STAGE AT DIAGNOSIS
THE ISSUE OF STAGE AT DIAGNOSIS IN SURVIVAL ANALYSIS Pamela Minicozzi Analytical Epidemiology and Health Impact Unit Department of Preventive and Predictive Medicine, Fodazione IRCCS Istituto Nazionale
More informationTelephone: Learning objectives
BreastScreen WA Breast Cancer Screening Investigation of a New Breast Symptom Dr Eric Khong, Liaison GP Telephone: 13 20 50 Learning objectives Increased understanding of the availability, benefits and
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Hersch J, Barratt A, Jansen J, et al. Use of
More informationBreast Cancer Network Australia DXA bone mineral density survey May 2012
Breast Cancer Network Australia DXA bone mineral density survey May 212 I won't be having any more mineral density tests as I can't afford the high cost. Introduction Of the 14,2 women diagnosed with breast
More informationRethinking Breast Cancer Screening
Rethinking Breast Cancer Screening NAMS Meeting, October, 2014 Russell Harris, MD, MPH University of North Carolina, Chapel Hill Conflicts of Interest Financial: none Intellectual: I have been researching
More informationBreast Cancer Screening
Breast Cancer Screening Claire Frost, MD R3 Talks 1 Objective 1. Understand risks and benefits of screening by reviewing current literature 2. Evaluate major society recommendations on breast cancer screening
More informationSummary. Chapter 7. Breast cancer and screening
Chapter 7 Breast cancer and screening World-wide burden Breast cancer is the commonest cancer among women in both high-income and low-income countries, accounting for 22% of the 4.7 million new cases of
More informationUnderstanding Your Pathology Report
Understanding Your Pathology Report Because every person s breast cancer is unique, it s important to understand the underlying biology of your tumor to personalize your treatment plan. Your physicians
More informationPrognosis for metastatic breast cancer to bones
Prognosis for metastatic breast cancer to bones The Borg System is 100 % Prognosis for metastatic breast cancer to bones Jul 23, 2013. Purpose. Bone is the most frequent site of metastasis among breast
More informationPrevention and Screening for Breast Cancer
Cancer Expert Working Group on Cancer Prevention and Screening Prevention and Screening for Breast Cancer Information for women and their families 1 What is breast cancer? The female breast is mainly consisted
More informationExecutive summary. The usefulness of breast cancer screening
Executive summary Health Council of the Netherlands. Population screening for breast cancer: expectations and developments. The Hague: Health Council of the Netherlands, 2014; publication no. 2014/01 Randomized
More informationCOMPANION MEETING BREAST. Auditorium 11:15 1:00 am. Convenor: A/Professor Gelareh Farshid, SA Pathology, SA
Australasian Division of the International Academy of Pathology Limited ABN 73 008 593 815 36 TH Annual Scientific Meeting Darling Harbour Convention Centre, Sydney, Australia June 3-5, 2011 COMPANION
More informationBreast Density. Information for Health Professionals
Breast Density Information for Health Professionals BreastScreen NSW provides free screening mammography to asymptomatic women aged 50-74 every two years, with the aim of diagnosing breast cancer at an
More informationMammographic density and risk of breast cancer by tumor characteristics: a casecontrol
Krishnan et al. BMC Cancer (2017) 17:859 DOI 10.1186/s12885-017-3871-7 RESEARCH ARTICLE Mammographic density and risk of breast cancer by tumor characteristics: a casecontrol study Open Access Kavitha
More informationBMJ Open. How Different Terminology for Ductal Carcinoma in Situ Impacts Women s Concern and Treatment Preferences
How Different Terminology for Ductal Carcinoma in Situ Impacts Women s Concern and Treatment Preferences Journal: BMJ Open Manuscript ID: bmjopen-0-000 Article Type: Research Date Submitted by the Author:
More informationLife expectancy in the United States continues to lengthen.
Reduced Mammographic Screening May Explain Declines in Breast Carcinoma in Older Women Robert M. Kaplan, PhD and Sidney L. Saltzstein, MD, MPH wz OBJECTIVES: To examine whether declines in breast cancer
More informationUpdate from the 29th Annual San Antonio Breast Cancer Symposium
Update from the 29th Annual San Antonio Breast Cancer Symposium The San Antonio Breast Cancer Symposium is one of the most important breast cancer conferences. Approximately 8,000 physicians, oncologists,
More informationPET/CT in breast cancer staging
PET/CT in breast cancer staging Anni Morsing Consultant, PhD, DMSc Rigshospitalet 1 18F- FDG PET/CT for breastcancer staging Where is the clinical impact? To which women should 18F- FDG PET/CT be offered?
More informationBreastScreen Australia monitoring report
BreastScreen Australia monitoring report 2012 2013 CANCER series No. 95 CANCER SERIES Number 95 BreastScreen Australia monitoring report 2012 2013 Australian Institute of Health and Welfare Canberra Cat.
More informationPrevalence of incidental breast cancer and precursor lesions in autopsy studies: a systematic review and meta-analysis
Thomas et al. BMC Cancer (1) 1: DOI.11/s1-1-3-1 RESEARCH ARTICLE Open Access Prevalence of incidental breast cancer and precursor lesions in autopsy studies: a systematic review and meta-analysis Elizabeth
More informationThe U.S. Preventive Services Task Force (USPSTF) CLINICAL GUIDELINE
Annals of Internal Medicine CLINICAL GUIDELINE Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement Albert L. Siu, MD, MSPH, on behalf of the U.S. Preventive Services
More informationEffective breast cancer screening should reduce the ORIGINAL RESEARCH
Annals of Internal Medicine ORIGINAL RESEARCH A Cohort Study of Tumor Size and Overdiagnosis Karsten Juhl Jørgensen, MD, DrMedSci; Peter C. Gøtzsche, MD, MSc; Mette Kalager, MD, PhD*; and Per-Henrik Zahl,
More informationCarcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS
Carcinoma mammario: le istologie non frequenti Valentina Guarneri Università di Padova IOV-IRCCS Histological diversity of breast adenocarcinomas Different histological types are defined according to specific
More informationAngela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008
Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008 Breast Cancer Most common cancer in American women 180,000 new cases per year Second most common cause of cancer death 44,000
More informationBreast Cancer Staging
Breast Cancer Staging Symposium on Best Practice in Recording Cancer Stage Royal College of Pathologists 10 June 2011 Dr Gill Lawrence, Director Tel: 0121 415 8129 Fax: 0121 414 7712 Email: gill.lawrence@wmciu.nhs.uk
More informationQuantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme
British Journal of Cancer (2002) 87, 65 69 All rights reserved 0007 0920/02 $25.00 www.bjcancer.com Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme
More informationScreening for Prostate Cancer: A Consideration
Screening for Prostate Cancer: A Consideration of Screening Factors in Comparison to Screening for Breast Cancer Abstract S Jones Research Fellow Centre for Behavioural Research in Cancer Control Division
More informationNational Breast Cancer Audit next steps. Martin Lee
National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast
More informationCLINICAL-PATHOLOGICAL INDICATORS OF AN OPPORTUNISTIC BREAST CANCER SCREENING: A POPULATION-BASED STUDY
CLINICAL-PATHOLOGICAL INDICATORS OF AN OPPORTUNISTIC BREAST CANCER SCREENING: A POPULATION-BASED STUDY Bordoni A, Probst-Hensch NM, Mazzucchelli L, Spitale A Registro Tumori Canton Ticino Istituto Cantonale
More informationIL Balance Sheet dei programmi di screening mammografici dell Unione Europea
Seminario di studio LA SORVEGLIANZA EPIDEMIOLOGICA DELLO SCREENING DEI TUMORI DELLA MAMMELLA NELLA REGIONE EMILIA-ROMAGNA Bologna, 18 marzo 2013 IL Balance Sheet dei programmi di screening mammografici
More informationScreening for breast cancer
Screening for breast cancer Joining BreastScreen Aotearoa www.timetoscreen.nz What is breast screening? Breast screening means having a mammogram to check for early signs of breast cancer. A mammogram
More informationCANCER IN NSW ABORIGINAL PEOPLES. Incidence, mortality and survival September 2012
CANCER IN NSW ABORIGINAL PEOPLES Incidence, mortality and survival September 2012 CANCER IN NSW ABORIGINAL PEOPLES Contents Tables 1 Figures 2 Message from the Chief Cancer Officer 4 Executive summary
More informationBreast cancer screening: emerging role of new imaging techniques as adjuncts to mammography
Breast cancer screening: emerging role of new imaging techniques as adjuncts to mammography Nehmat Houssami, Sarah J Lord and Stefano Ciatto Randomised trials of mammography screening have shown that early
More informationSurvival outcomes for men in rural and remote NSW. Trend in prostate cancer incidence and mortality rates in Australia. The prostate cancer conundrum
7/8/20 7/8/20 Using PROMS to better understand prostate cancer outcomes: The NSW Prostate Cancer Care and Outcomes Study David Smith Research Fellow Cancer Research Division Monash Uni, 26 th June 20 Survival
More informationOverdiagnosis and Overtreatment of Prostate Cancer and Breast Cancer Due to Screening
Overdiagnosis and Overtreatment of Prostate Cancer and Breast Cancer Due to Screening By Jeremy Littleton A Master's Paper submitted to the faculty of the University ofnorth Carolina at Chapel Hill In
More informationEffect of Three Decades of Screening Mammography on Breast-Cancer Incidence
T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence Archie Bleyer, M.D., and H. Gilbert Welch, M.D., M.P.H.
More informationBreast Cancer Screening: Changing Philosophies in Educating Women and Teens
Breast Cancer Screening: Changing Philosophies in Educating Women and Teens Courtney Benedict CNM MSN Disclosures Merck Nexplanon trainer Session Objectives Explain the rationale for initiation and frequency
More informationScreening Mammography Among Women With A Family History Of Breast Cancer
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine January 2014 Screening Mammography Among Women With A Family History
More informationThe Australian BreastScreen workforce: a snapshot
Original article Volume 59 (1) 2012 The Australian BreastScreen workforce: a snapshot S Moran British Diploma of Diagnostic Radiography H Warren Forward Bsc (Hons), Phd Medical Radiation Science Hunter
More informationSCREENING FOR BREAST CANCER IN ENGLAND: PAST AND FUTURE
SCREENING FOR BREAST CANCER IN ENGLAND: PAST AND FUTURE Advisory Committee on Breast Cancer Screening* NHSBSP Publication No 61 February 2006 *Members of the Advisory Committee on Breast Cancer Screening:
More informationBREAST CANCER SCREENING IS A CHOICE
BREAST CANCER SCREENING IS A CHOICE by ELAINE SCHATTNER, MD no financial disclosures (ES) American Association for Cancer Research Typical headlines focus on controversy 2 Data: Breast Cancer Incidence
More informationGETTING A GRIP. A Report Into Breast Health Understanding Among Women In Australia
GETTING A GRIP A Report Into Breast Health Understanding Among Women In Australia Based on independent research carried out by AMR for the McGrath Foundation October 2016 FOREWORD With the sheer number
More informationBreast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined
Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases
More informationBREAST CANCER d an BREAST SELF EXAM
BREAST CANCER and BREAST SELF EXAM American Cancer Society Statistics: 2009 Invasive breast cancer will be diagnosed in over 192,370 women Carcinoma in situ will be diagnosed in 62,280 women More than
More informationBreast Cancer. Saima Saeed MD
Breast Cancer Saima Saeed MD Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women 1 in 8 women will develop breast cancer Incidence/mortality rates have declined Breast
More informationAttending Physician Statement- Cancer or Carcinoma in-situ
Instruction to doctor: This patient is insured with us against the happening of certain contingent events associated with his health. A claim has been submitted in connection with Cancer or Carcinoma in-situ.
More informationNational AIDS Registry
National AIDS Registry Table 1.1 Cases of AIDS and deaths following AIDS by sex and State/Territory in which diagnosis of AIDS was made, cumulative to 31 December 2006, and for two previous yearly intervals
More informationSupplementary Online Content
Supplementary Online Content Giannakeas V, Sopik V, Narod SA. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy. JAMA Netw Open. 2018;1(4):e181100.
More information